
Thomas Flaig
@tomflaigmd
Medical Oncologist | Vice Chancellor for Research @CUAnschutz @CUDenver | #BladderCancer #ProstateCancer Research | Tweets are my own
ID: 1532113348849913856
01-06-2022 21:36:14
840 Tweet
2,2K Followers
1,1K Following


New research study from CU Anschutz Medical Campus in Annals of Int Med examines weight loss with intermittent fasting for three days a week versus slightly reducing calories every day. Read More: health.com/intermittent-f…

Thank you to Representative Jason Crow for visiting CU Anschutz Medical Campus last week to learn more about our latest medical research and the critical role of federal funding in advancing new discoveries.


New research from CU Anschutz Medical Campus is the first to identify defects related to metabolism in lymphoblast cell lines derived from blood samples of children with Dravet syndrome, which could lead to new treatments for epilepsy and related disorders. news.cuanschutz.edu/news-stories/f…

A study from ColoradoSPH reveals that nearly 1 in 5 U.S. adults used multiple drugs in the past year, indicating that substance use is both common and nuanced. The research underscores the need for more personalized drug prevention & treatment programs. news.cuanschutz.edu/news-stories/s…


New study in Journal of Clinical Investigation led by CU School of Medicine found that in the absence of B cells, CD8 T-cells become overly active and burn out quickly, thus failing to mount a lasting immune response after vaccination. news.cuanschutz.edu/news-stories/b…

New study led by Dr. Dana Dabelea from ColoradoSPH finds that children exposed to gestational diabetes in utero with a specific variation of a common gene are at a higher risk of becoming overweight or obese during childhood. news.cuanschutz.edu/news-stories/a…

Studies show that physical activity can delay the progression of #Parkinsons. Now the CU Physical Therapy program is doing cutting-edge research to determine how exercise can best help patients to alleviate symptoms of the disease. news.cuanschutz.edu/news-stories/s…

This Q&A with Casey Greene provides a nice summary of the current state of #ArtificialInteligence in healthcare, future developments on the horizon, and the potential opportunities and pitfalls of these technologies - for both providers and patients. news.cuanschutz.edu/news-stories/a…

An insightful article in Military.com from CU Center for COMBAT Research researchers about the unique psychological stressors that children of military families experience, as well as the barriers they face in accessing mental health care. military.com/daily-news/opi…

Learn how our Investigational New Drug and Device team is supporting researchers CU Anschutz Medical Campus to expedite CAR T-cell discoveries and translation this work from the laboratory to clinic. youtube.com/watch?v=yP8XGR…


Congratulations to the four CU Anschutz scientists who were recently named to the 2025 class of Boettcher Investigators, and thank you to the Boettcher Foundation for their generous support of life-saving biomedical research at CU Anschutz Medical Campus!

Scientists at CU Anschutz Medical Campus may have found a connection between gingivitis and rheumatoid arthritis. New study reveals that joint tissue from early-stage RA patients often has high levels of granzyme and remnants of a bacteria that causes gum disease. news.cuanschutz.edu/news-stories/r…



As a dog-lover, I enjoyed this story about a therapy dog named Otis that’s helping people with OCD undergoing treatment at Department of Psychiatry at CU Anschutz. cbsnews.com/colorado/video…


Thanks to an anonymous $2M gift, the Interventional Cardiology Endowed Chair was recently established within CU School of Medicine's Division of Cardiology. Dr. John Messenger will serve as chairholder, leading new innovations in minimally invasive, catheter-based techniques.

